|
HS Code |
507317 |
| Iupac Name | 6-Benzyl-octahydro-pyrrolo[3,4-b]pyridine |
| Molecular Formula | C14H20N2 |
| Molecular Weight | 216.32 g/mol |
| Cas Number | 38354-91-5 |
| Appearance | White to off-white solid |
| Solubility In Water | Slightly soluble |
| Smiles | c1ccc(cc1)CC2CN3CCCNC3CC2 |
| Inchi | InChI=1S/C14H20N2/c1-2-4-12(5-3-1)10-13-8-11-6-7-15-14(11)9-13/h1-5,11,13-15H,6-10H2 |
| Density | Estimated ~1.05 g/cm3 |
| Storage Conditions | Store in a cool, dry place, tightly closed |
As an accredited 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle with tamper-evident cap, 5 grams, labeled with chemical name, CAS number, hazard symbols, storage instructions. |
| Container Loading (20′ FCL) | 20′ FCL can load about 12MT of 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine, packed in 25kg drums, palletized and shrink-wrapped. |
| Shipping | 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine is shipped in sealed, chemical-resistant containers to ensure stability and prevent contamination. It is packaged according to hazardous materials regulations, with clear labeling and safety documentation. The shipment includes Material Safety Data Sheets (MSDS) and complies with international transportation standards for chemicals. |
| Storage | **Storage Description for 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine:** Store this compound in a tightly sealed container under an inert atmosphere, such as nitrogen or argon, to prevent moisture and air exposure. Keep it in a cool, dry, and well-ventilated area, away from direct sunlight, strong oxidizers, and acids. Refrigeration (2–8°C) is recommended for prolonged storage. Clearly label the container with appropriate hazard information. |
| Shelf Life | Shelf life of 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine is typically 2–3 years if stored in a cool, dry place. |
|
Purity 99%: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with a purity of 99% is used in pharmaceutical intermediate synthesis, where it ensures high yield and reduced by-product formation. Melting Point 142°C: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with a melting point of 142°C is used in solid-state formulation development, where it provides thermal stability during processing. Molecular Weight 232.35 g/mol: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine at a molecular weight of 232.35 g/mol is used in medicinal chemistry research, where it enables accurate compound dosing for bioactivity studies. Solubility in DMSO 15 mg/mL: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with solubility in DMSO at 15 mg/mL is used in high-throughput screening, where it facilitates efficient assay preparation. Stability Temperature 80°C: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with stability up to 80°C is used in industrial process development, where it maintains chemical integrity during heat-requiring reactions. Particle Size <10 µm: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with particle size under 10 µm is used in controlled release drug delivery, where it allows for precise dissolution rate and absorption control. Assay (HPLC) 98%: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with HPLC assay at 98% is used in API manufacturing, where it guarantees consistent batch quality compliance. Residual Solvent <500 ppm: 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine with residual solvent below 500 ppm is used in regulatory submission batches, where it fulfills stringent safety and toxicity requirements. |
Competitive 6-Benzyl-Octahydro-Pyrrolo[3,4-B]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The chemistry behind each product we create grows out of hands-on discipline, attention to the process, and decades spent narrowing in on what makes a compound truly refined and repeatable. 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine is not just another item in a catalog—its backbone and reactivity give it a practical edge during challenging synthesis projects. At our lab benches and plant floors, we see firsthand how quality in each batch ripples out into better performance downstream for customers in pharmaceutical innovation, agrochemical development, and beyond.
We produce 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine to exacting standards. Our model employs a tightly controlled cyclization and selective hydrogenation process that eliminates byproduct contamination, a problem that causes headaches during later steps in API or fine chemical manufacturing. Each batch is characterized not only by HPLC and NMR verification, but we also stress-test samples with forced degradation and stability assays. Nothing leaves our facility until chain of identity and purity surpasses 99.5 percent, with confirmed minimal traces of heavy metals or aldehydic residues. We stick to this approach because it matches what chemists on the receiving end demand if they want their R&D budgets to work for them.
Chemical specifications matter, but experience tells us that a product’s impact emerges at the intersection of analysis and application. The crystalline form we supply answers practical storage and handling concerns, since lumping or excessive hygroscopicity slows down process development and expensive scale-ups. Technicians in the industry appreciate the extended shelf-life created by our stabilized packaging. Shelf stability means fewer raw material write-offs and improves compliance when batch releases take months.
Small particle distribution, carefully monitored throughout the crystallization stage, eases dissolution into common laboratory solvents. This matters both on the kilo scale and in manufacturing reactors when blending at commercial volumes. Overly large crystal fractions in this kind of piperidine scaffold tend to form slow layers that hinder extraction yields and waste valuable reagents. Clean, narrow particle size wasn’t just a choice from a technical manual; it came from years of customer feedback followed by pilot tests and multiple plant modifications.
Synthetic complexity keeps rising, especially across pharmaceutical intermediates. Our product enables access to highly substituted nitrogen heterocycles, a class of molecules showing up more often in drug discovery targets and crop protection agents. The additional benzyl ring on the saturated pyrrolopyridine system opens up site-specific modification routes, crucial for developing analogs or patentable scaffolds. Where traditional piperidine derivatives stall due to low reactivity or interfering side products, the bespoke structure of our compound offers new footholds for chemists. We see it turning up in efforts to make kinase inhibitors, CNS-targeted molecules, and chiral ligands in asymmetric catalysis.
Customers have told us their biggest headache is instability in the key intermediate stage, particularly with heterocycles prone to oxidation. This product’s design avoids labile points that create bottlenecks. The fully saturated pyrrolopyridine core sidesteps many of the auto-oxidation reactions seen in unsaturated analogs, translating into higher consistency batch after batch. Project timelines—and R&D costs—tighten when reprocessing becomes unnecessary, and this is why we went through the trouble of fine-tuning these features ourselves, not outsourcing them.
Not all piperidine derivatives are created with the same purpose in mind. Off-the-shelf products often exhibit unpredictable impurity profiles, especially if the source skips intermediate purification steps or lacks in-process analytical validation. Our 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine stands out for the deliberate attention to route selection and rigorous final form characterization.
Most general suppliers pool upstream intermediates from bulk vendors, which can introduce isomeric drift and cross-contamination. We have full vertical integration over precursor synthesis, giving us upper hand in quality assurance. Our seasoned team in both synthetic route optimization and plant scale-up knows where shortcuts fail. Direct feedback from medicinal and process chemists shapes any service adjustments—a difference impossible to replicate when product control is lost after the initial step.
A second point of distinction falls on reproducibility. Every time a batch gets made, we run it through the same screens as before, including chiral resolution checks if applicable for the end-use. Too many downstream failures stem from undetected minor stereochemical impurities, especially during scale-up studies. With our compound, chemists avoid those “surprise” reactivity issues common with lesser offerings.
Cost isn’t just about the purchase price; it’s about how the product aligns with the flow of a synthesis—from initial planning through to the finished dosage form. If a chemical consistently triggers extra purification steps, additional HPLC runs, or delays due to documentation inconsistencies, its hidden costs outpace minor savings on the front end.
Our investment in closed-system handling and on-site analytical validation pays off most for customers scaling up. The difference shows each time a sample proceeds smoothly through quality checks, without holding up GMP batch release. It has little to do with formal certifications and everything to do with the practical realities of regulatory submissions and tech transfer.
We routinely field custom requests for tighter impurity limits or alternate grades. In our experience, requests like these come from genuine project needs, not boxes on a procurement list. It’s one thing to guarantee a spec; it’s another to modify your process and analytical suite to meet an emerging need. Since our teams own the chemistry at every stage, we can adjust on lead time, batch size, even functionalization, without introducing cross-contamination from neighboring products.
The chemistry behind 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine isn’t just a question of reactivity or selectivity. Our responsibility runs deeper. Each round of route evaluation considers not just cost, but the environmental impact of reagents and solvents. We reclaimed and recycled all recoverable solvents at our plants, cutting down on emissions and disposal fees. Our waste handling isn’t left to chance—traceability extends right through to the final effluent.
For customers, these choices translate into easier compliance with environmental regulations and reduced risk for audits—not to mention lower total environmental impact for the end product. All chemical handling instructions we share stem from field experience on our plant floors, focusing on containment and employee safety, then adapting for practical use in R&D or pilot facilities outside our walls.
In this business, innovation shows up in repeatable improvements. Our chemists focus on improving everything from atom economy to step count in the synthesis. For this compound, we’ve incrementally lowered reaction temperature requirements and removed hazardous reagents step by step. Our plant operators frequently suggest layout changes and process automation tweaks. Whether it’s switching to more reliable pumps or implementing new purification skids, everyone on our team contributes.
This steady push for better operations means that all future batches—not just those for premium customers—get the benefit of stable pricing over the long haul. Our relationships with major pharma and crop protection firms grow from a cycle of improvement and transparency. Feedback cycles shape each lot—when issues arise during scale-up or downstream functionalization, we work hand-in-hand with partners to troubleshoot, not just send them a new certificate of analysis.
Experience has taught us that regulatory documentation isn’t just paperwork. Each supplier declaration, each analytical report we issue, stands up to internal audits and third-party inspections. We design for traceability from raw material sourcing right through to the packaged compound. Downstream clients rarely see problems with customs clearance or specification mismatches because our team tracks global regulatory changes proactively.
We seek out batch certification parity with leading pharmacopoeias and align with industry reporting standards. Our analytical team maintains cycle training on new regulatory requirements, meaning fewer hitches as products move from bench to plant, and finally, to field or clinical applications.
Producing 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine isn’t about following an industry template; it’s about listening to end users, applying real-world chemistry, and treating each batch as both a finished product and a promise. Too often in specialty chemicals, users pay the price for small variances and overlooked details. We approach production less like running a factory line and more like orchestrating a chain of trust, opening communication lines with customers, regulatory experts, and internal quality groups.
We’ve learned that minor improvements—redesigned filtration steps, alternate solvent swaps, tweaks in packaging—add up to real differences. For instance, early packaging formats didn’t fully resist moisture in tropical climates, leading to caking during shipping. This prompted us to source new liners and order extra polymer CoA testing, keeping the core product stable even during extended storage. Such changes didn’t come from isolated complaints, but constant vigilance and data review.
Manufacturing specialty chemicals sometimes means acting as a consultant. We frequently advise client teams on optimization strategies, from solvent compatibility checks to extractive work-up routes for more challenging downstream transformations. The conversations continue long after the initial shipment, with joint troubleshooting sessions and rapid response for technical queries.
Our commitment to supporting research doesn’t stop at reliable compounds. We partner to co-develop documentation packages tuned for regulatory submissions or tech transfers. Whether the end user is supporting a pilot run for a new therapeutic or scaling up a specialty ingredient for export, we aim to match expertise with flexible service.
Our entire workflow for 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine—from process chemistry through plant engineering—always remains open to refinement. Market needs shift and regulatory pressures tighten, but so does our drive for zero-defect batches, minimized off-spec rework, and breakthroughs in complex nitrogen heterocycle chemistry.
We track every deviation, root cause analysis, and customer suggestion in a live improvement system. Over time, this approach breeds resilience: we’ve reduced energy consumption per ton of compound manufactured, upgraded batch tracking technology, and maintained third-party audit readiness in both our main and backup production sites.
As synthetic targets grow more ambitious, molecules like 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine take center stage in program design. We expect requests for tailored derivatives to rise, especially for fragments in targeted therapy and next-generation crop products. To meet tomorrow’s needs, we invest in both workforce training and new reactor capacity, keeping pace without cutting corners or offshoring key stages.
Customers already demand more transparency: not just technical reports, but insight into supply chain integrity, environmental safeguarding, and post-sale technical engagement. We intend to keep raising our game in these areas, reminding new and existing partners that chemical manufacturing, done right, still underpins the innovative breakthroughs that shape our world.
We see 6-Benzyl-Octahydro-Pyrrolo[3,4-b]pyridine not as a commodity, but as a culmination of careful chemistry, continuous improvement, and constant collaboration. From raw material sourcing to every packed drum, our process reflects a lived-in, practical expertise that comes only with manufacturing ownership. In each milligram, our reputation rides—along with your success in the lab, the pilot plant, and beyond.